ALDEYRA THERAPEUTICS, INC. Peo Actually Paid Comp Amt
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Peo Actually Paid Comp Amt of $4.29 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-27.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-27
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $4.29M DEF 14A · filed 2026-04-27 |
| 2024-12-31 | $6.05M DEF 14A · filed 2026-04-27 |
| 2023-12-31 | -$1.22M DEF 14A · filed 2026-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |